Drugs / KIRIM-KONGO-VAX
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03020771 Comparator | Dec 2014 → Jun 2017 | Crimean-Congo hemorrhagic fever | The Scientific and Technological Research Council of Turkey | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KIRIM-KONGO-VAX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03020771 ↗ |
| Modality | Vaccine | “Crimean-Congo Hemorrhagic Fever Vaccine” NCT03020771 ↗ |
| Route | Intramuscular | “administered Subcutaneously or Intramuscularly” NCT03020771 ↗ |
| Route | Subcutaneous | “administered Subcutaneously or Intramuscularly” NCT03020771 ↗ |